The Clinical Efficacy, Safety, and Tolerability of Vancomycin for the Treatment of Recurrent Clostridioides difficile Infection – A Systematic Review
Maja Johanne Søndergaard Knudsen,1,* Ingrid Maria Cecilia Rubin,1,* Andreas Munk Petersen1– 3 1Department of Clinical Microbiology, Copenhagen University Hospital – Amager and Hvidovre, Hvidovre, Denmark; 2Department of Gastroenterology, Copenhagen University Hospital – Amager and Hv...
Main Authors: | Knudsen MJS, Rubin IMC, Petersen AM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-03-01
|
Series: | Drug, Healthcare and Patient Safety |
Subjects: | |
Online Access: | https://www.dovepress.com/the-clinical-efficacy-safety-and-tolerability-of-vancomycin-for-the-tr-peer-reviewed-fulltext-article-DHPS |
Similar Items
-
Inhibition of spores to prevent the recurrence of Clostridioides difficile infection - A possibility or an improbability?
by: Chun-Wei Chiu, et al.
Published: (2021-12-01) -
The Risk of <i>Clostridioides difficile</i> Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts
by: Ronald G. Hall, et al.
Published: (2022-02-01) -
Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection — An observational cohort study
by: Sylvia Polivkova, et al.
Published: (2021-02-01) -
Efficacy of prolonged tapered and pulsed vancomycin regimen on recurrent Clostridioides difficile infection in the Japanese setting: a case control study
by: Takumi Umemura, et al.
Published: (2019-08-01) -
<i>Clostridioides difficile</i> infection in hospital and community settings: summary document of a multidisciplinary group
by: Anna Danise, et al.
Published: (2024-02-01)